In a search for pathophysiological causes of idiopathic male infertility we investigated the occurrence of mutations of the FSH receptor in 48 men with this disorder. The entire FSH receptor gene was analyzed by single stranded conformation polymorphism analysis (SSCP). A heterozygous point mutation without functional consequences, exchanging Val to Ala in codon 341, was found in one patient. SSCP analysis led to the identification of 2 polymorphisms in exon 10 associated in 2 discrete FSH receptor allelic variants, i. T HE PRODUCTION of gametes depends on the concerted action of the two gonadotropins FSH and LH on the gonads. In the male, FSH is required for the determination of Sertoli cell number and for the induction and maintenance of qualitatively and quantitatively normal spermatogenesis (1, 2). FSH acts through binding to its specific receptor, a member of the G protein-coupled receptor family (3, 4). Men with a homozygous inactivating mutation of the FSH receptor have reduced testicular volume, increased serum FSH concentration, and variable degrees of spermatogenic damage (5). The crucial importance of FSH for male gonadal function is demonstrated by the recent description of infertility in a man with a mutation in the FSH ␤-subunit gene (6) and in male mice in which the FSH receptor has been knocked out (7). These findings suggest that mutations of the FSH receptor could play a pathogenetic role in male infertility. In a previous study, we did not find mutations of the FSH receptor in a group of 19 infertile men with histologically documented focal or complete Sertoli cell only syndrome (8). The studies described in this paper extend our previous observation to a larger group of infertile men. As during this investigation two polymorphisms were found in exon 10, we proceeded to analyze the FSH receptor polymorphism in infertile men and in a large group of men with proven fertility. Finally, we studied the functional characteristics of the naturally occurring FSH receptor allelic variants in vitro and in vivo.
Asn 680 and Ala 307 -Ser 680 . The frequency and distribution of the two allelic variants was further analyzed in 86 proven fathers and 75 infertile men by SSCP (codon 307) and restriction fragment length polymorphism (codon 680). The 2 receptor isoforms showed similar Mendelian distribution in proven fathers and in infertile men. Serum FSH, inhibin B, and combined testicular volume did not differ between subjects with different receptor isoforms. Binding studies in transiently transfected COS-7 cells showed similar binding affinity for the two receptor variants. Moreover, the Ala 307 -Ser 680 and the Thr 307 -Asn 680 FSH receptors responded in vitro to FSH with comparable cAMP production. These data suggest that different isoforms of the FSH receptor with similar functional properties exist in normal and infertile men. We conclude that mutations of the FSH receptor or the FSH receptor genotype do not play a pathogenic role in male idiopathic infertility. The possibility that different FSH isoforms might interact differently with the 2 receptor variants remains to be investigated. (J Clin Endocrinol Metab 84: [751] [752] [753] [754] [755] 1999) T HE PRODUCTION of gametes depends on the concerted action of the two gonadotropins FSH and LH on the gonads. In the male, FSH is required for the determination of Sertoli cell number and for the induction and maintenance of qualitatively and quantitatively normal spermatogenesis (1, 2) . FSH acts through binding to its specific receptor, a member of the G protein-coupled receptor family (3, 4) . Men with a homozygous inactivating mutation of the FSH receptor have reduced testicular volume, increased serum FSH concentration, and variable degrees of spermatogenic damage (5) . The crucial importance of FSH for male gonadal function is demonstrated by the recent description of infertility in a man with a mutation in the FSH ␤-subunit gene (6) and in male mice in which the FSH receptor has been knocked out (7) . These findings suggest that mutations of the FSH receptor could play a pathogenetic role in male infertility. In a previous study, we did not find mutations of the FSH receptor in a group of 19 infertile men with histologically documented focal or complete Sertoli cell only syndrome (8) . The studies described in this paper extend our previous observation to a larger group of infertile men. As during this investigation two polymorphisms were found in exon 10 , we proceeded to analyze the FSH receptor polymorphism in infertile men and in a large group of men with proven fertility. Finally, we studied the functional characteristics of the naturally occurring FSH receptor allelic variants in vitro and in vivo.
Subjects and Methods Subjects
Study 1: mutational analysis of the FSH receptor in male infertility. Mutational analysis of the FSH receptor was performed in 48 patients consulting our infertility clinic. All patients gave informed consent to participate in the study. The clinical parameters of the patients are shown in Table 1 . This group includes 22 patients with nonobstructive azoospermia, 24 patients with severe oligozoospermia (sperm concentration, Ͻ10 ϫ 10 6 /mL; median value, 0.4 ϫ 10 6 /mL), and 2 patients with slightly reduced sperm concentration. Serum FSH levels were above the upper normal limit (Ͼ7 IU/L) in 17 azoospermic patients, 14 oligozoospermic patients, and 2 infertile men with slightly reduced sperm concentrations. The remaining subjects had normal FSH levels, and obstruction was excluded by testicular biopsy, sonography, and chemical markers of ductal patency in the seminal plasma. The median FSH concentration values were 22.3 and 9.6 IU/L in the azoospermic and severely oligozoospermic groups, respectively. Testicular histology was available in 16 azoospermic men and showed complete SCO in 12 cases and spermatogenic arrest at the stage of primary spermatocytes in 4 cases. In 11 oligozoospermic patients, testicular histology showed monolateral or focal SCO, in 2 patients spermatogenic arrest, and in 1 decreased spermatogenesis.
Study 2: frequency of the allelic variants of the FSH receptor in proven fathers and infertile men. The incidence of the 2 FSH receptor alleles was analyzed in 86 proven fathers and in 75 infertile men. The proven fathers were recruited in part through advertisements in local newspapers (n ϭ 46) and in part by soliciting male blood donors at the time of blood donation (n ϭ 40). Inclusion criteria were paternity achieved within the last 5 yr and age less than 45 yr. The 75 infertile men consisted of 30 azoospermic men and 45 men with severe oligozoospermia (median sperm concentration, 0.6 ϫ 10 6 /mL) selected by the same criteria as the patients in study 1. All subjects gave their informed consent to take part in the study. Forty-five patients were included in both studies 1 and 2.
Clinical parameters
All serum hormones were measured in duplicate. Serum FSH and LH were assayed by immunofluorimetric assay using the Autodelfia system (Wallac, Freiburg, Germany). The sensitivities were 0.05 and 0.025 IU/L for FSH and LH, respectively. The intra-and interassay coefficients of variation (CVs) were less than 3% for both hormones. Serum testosterone was measured by RIA using a direct method (DSL, Sinsheim, Germany). The sensitivity and intra-and interassay CVs were 0.4 nmol/L, 5.5%, and 9.2%, respectively. Serum inhibin B was measured by enzyme-linked immunosorbent assay (9) using the Serotec inhibin B dimer assay kit (Camon, Wiesbaden, Germany) according to the instructions of the manufacturer. The sensitivity was 7.8 pg/mL. Intra-and interassay CVs were 2.5% and 6.7%, respectively. Semen analysis was performed according to the WHO guidelines (10) . Testicular volume was determined by ultrasonography, using Sonoline SL2 equipment (Siemens, Erlangen, Germany) (11) .
DNA isolation and analysis
Genomic DNA was obtained from peripheral blood leukocytes as previously described (12) . The entire FSH receptor gene was screened for mutations by single stranded conformation polymorphism (SSCP) gel electrophoresis. Exons 1-9, encoding the extracellular domain of the FSH receptor, were amplified by PCR using primers flanking each exon as previously described (13) . The PCR amplification of exon 10, encoding the transmembrane and intracellular domains, SSCP and sequence analysis were performed as described previously (12) . The SSCP analysis was employed for the characterization of the polymorphism at position 307. The SSCP results were confirmed by direct sequencing of about 10% of randomly chosen DNA samples .
Restriction fragment length polymorphism (RFLP) of the Asn 680 Ser variant
The presence of the Asn 680 Ser variant introduces a restriction site that can be exploited in the RFLP technique. A fragment of exon 10, 10E to 10G (12), was amplified from genomic DNA. The PCR fragment was purified by purification columns (Qiagen, Hilden, Germany) and further subjected to restriction digestion by Bsr1. After digestion, the fragments were run on a 2% agarose gel electrophoresis and analyzed. The uncleaved fragment, homozygous for Asn, has a size of 579 bp, whereas the cleaved fragment, homozygous for Ser, gives rise to 443-and 136-bp fragments. The presence of all three fragments indicated a heterozygous state.
Mutagenesis, transfection of COS-7 cells, and cAMP assay
The human FSH receptor complementary DNA originally cloned in the EcoRI restriction site of pSG5 (Stratagene, Heidelberg, Germany) carries ACT (Thr) in codon 307 and AAT (Asn) in codon 680. These two sites were mutagenized to GCT (Ala) and AGT (Ser), respectively, by oligonucleotide-directed mutagenesis using the Transformer Site-Directed Mutagenesis Kit (Clontech, Heidelberg, Germany).
Transfection experiments were carried out in COS-7 cells essentially as previously described (12) . In preliminary experiments the transfection conditions were optimized to obtain about a 50% transfection rate using 7.5 g/mL Lipofectamine reagent (Life Technologies, Eggenstein, Germany) and 2 g/mL plasmid DNA. Transfection efficiency was checked by transfecting the cells with the pcDNA3.1/His/lacZ plasmid. Twentyfour hours after transfection, cells were washed and stimulated with human recombinant FSH (Serono Laboratories, Inc., Aubonne, Switzerland) as previously described (12) . cAMP in the medium was measured by a cAMP enzyme-linked immunosorbent assay kit (IHF, Hamburg, Germany).
Binding studies
The binding characteristics of the two allelic variants of the FSH receptor were studied in transiently transfected COS-7 cells as described by van Loenen et al. (14) . COS-7 cells seeded in 24-well plates were transfected as described above. Twenty-four hours after transfection, 
Statistical analysis
All clinical variables were checked for normal distribution in the Kolmogorov-Smirnov test. Statistical analysis between the groups was then performed by t test. Differences in the distribution of proportions between the groups were tested by 2 test. Two-sided P Ͻ 0.05 were considered significant. These analyses were performed using the statistical software SigmaStat for Windows, version 2.0 (SPSS, San Rafael, CA). Statistical analysis of binding and functional parameters of transiently transfected COS-7 cells was performed on log-transformed data using the GraphPad Prism program.
Results

Study 1: mutational analysis of the FSH receptor in male infertility
No aberrant SSCP migration pattern was detected in exons 1-9 in any subject. In several patients, the SSCP analysis showed two possible patterns of migration on gel electrophoresis of the amplified fragments A and G of exon 10. Sequencing revealed that codon 307, in the extracellular domain, could be occupied by either ACT (Thr) or GCT (Ala) and that codon 680 could be occupied by either AGT (Ser) or AAT (Asn). These data confirm two previously reported polymorphisms (3, 4, 15-17) . A nonpolymorphic heterozygous point mutation was found in one patient, exchanging GTG (Val) in codon 341 to GCG (Ala). This patient had only one testis (volume, 17 mL) because of a possible testicular malformation on the left side and was azoospermic. His serum FSH level was 34 IU/L, and his inhibin B concentration was 12.4 pg/mL. The histology of the right testis showed spermatogenic arrest at the stage of primary spermatocytes. In vitro studies in transiently transfected COS-7 cells showed that the mutated receptor was normally responsive to FSH stimulation (not shown). Therefore, this heterozygous mutation is not expected to result in any impairment of receptor function. No other mutations were identified.
Study 2: frequency of the allelic variants of the FSH receptor in proven fathers and infertile men
The finding that the FSH receptor can be polymorphic at two positions in infertile men prompted us to analyze the frequency and distribution of the polymorphic variants in proven fathers and in infertile patients. To this end, analysis of codon 307 was carried out by SSCP, whereas codon 680 was analyzed by RFLP (Fig. 1 ). This investigation revealed that at the genomic level, there is a tight linkage between the two polymorphic sites and the two polymorphisms occur as two discrete allelic variants, i.e. Thr 307 -Asn 680 and Ala 307 -Ser 680 , giving rise to two receptor isoforms at the protein level. The frequency and distribution of these two allelic variants in proven fathers and infertile patients are shown in variants, respectively), the difference was not statistically significant (n ϭ 3; P ϭ 0.39). These data suggest similar functional characteristics for the two receptor isoforms.
As possible parameters of the activities of the two allelic variants in vivo, we compared the serum levels of FSH and inhibin B and the combined testicular volumes of proven fathers and infertile men (Fig. 3) . These three parameters differed significantly between controls and patients, but no significant differences could be observed within the groups and between the subjects with different allelic variants, even when only the homozygous subjects were considered.
Discussion
Given the fundamental role of FSH in human spermatogenesis, we postulated that defects of the FSH receptor might be involved in some form of male infertility with azoospermia or severe oligozoospermia. The screening of a large number of infertile men, however, does not support this hypothesis, and extending our previous observation (8) , this study demonstrates that sporadic mutations of the FSH receptor are not a common finding in male infertility. To our knowledge, this is the largest cohort of male patients in which the FSH receptor has been systematically analyzed in its entirety. In addition, a recent study by Tuerlings et al. (17) , based on 23 oligozoospermic and 5 azoospermic men undergoing intracytoplasmatic sperm injection, did not detect mutations of the FSH receptor gene in such patients. Therefore, the only known mutation of the FSH receptor relevant to male infertility remains the Ala 189 Val homozygous substitution found in some Finnish families with hereditary primary amenorrhea (6, 15) . These results restrict the indication of mutational analysis of the FSH receptor to infertile men whose parents are related or with a history of amenorrhea/infertility in their family.
FSH receptor analysis in normal and infertile men confirmed our previous finding of two polymorphisms at positions 680 and 307 (3, 4) . The present investigation revealed for the first time that these polymorphisms occur in two possible arrangements, suggesting the existence of two discrete allelic variants of a gonadotropin receptor in the Cau- casian population. In contrast, the two polymorphic variants were reported to occur in linkage disequilibrium in Brazilian subjects, revealing ethnic differences (16) .
Comparison with the reported amino acid sequence of the FSH receptor cloned from other animal species shows that the position corresponding to the human FSH receptor position 307 is occupied by Thr in the cynomolgus monkey (18) ; by Ala in the bovine, equine, and ovine receptors (19 -21) ; and by Ile in the rat (22) , whereas position 680 is invariably occupied by Asn in all these species. As the occurrence of polymorphisms of the FSH receptor in animal species has not been investigated, it is difficult to assess whether and which of the two human alleles is phylogenetically more closely related to other species.
The presence of an Asn residue at position 680 introduces a potential glycosylation site, which might be important for posttranslational receptor processing and expression at the cell surface (23) , whereas a Ser residue could contribute to a potential phosphorylation site involved in receptor function. When transiently transfected in COS-7 cells, the Asn 680 receptor isoform showed only a slightly, not significantly higher expression at the cell surface. Common polymorphisms of G protein-coupled receptors are known to influence pathophysiological functions. For example, a polymorphism in the opsin gene accounts for genetic variations in sensitivity to long wavelength light (24) . A polymorphism in the glucagon receptor was more common in subjects with noninsulin-dependent diabetes mellitus (25) . Variants of the MSH receptor gene are associated with red hair and fair skin (26) . Moreover, a TSH receptor variant has been found to have enhanced sensitivity to TSH stimulation in vitro (27) . The two FSH receptor isoforms described in this paper show similar hormone affinity and cAMP production in vitro and in parameters of FSH action in vivo, at least in adult males. These data suggest that FSH receptor isoforms are not functionally different in normal and infertile men. However, we cannot exclude the possibility that different activities of the two receptor isoforms might become evident in other pathophysiological conditions. The existence of several FSH isoforms with different specific activities is well known (28) . It has been speculated that, depending on FSH isoform interaction, FSH receptors can couple to different signal transduction pathways and elicit different physiological responses (28) . Our finding that FSH receptor isoforms exist as well renders the pleiotropism of FSH action even more multifaceted. Conversely, receptor isoforms could be relevant to the action of synthetic hormone analogs (29, 30) and may have an important impact on drug development (31) . These possibilities should be analyzed in future studies. . The three clinical parameters did not differ significantly between subjects with different FSH receptor genotype in both controls and patients (by Kruskal-Wallis ANOVA).
The roughly Mendelian distributions of the two allelic variants were similar in fertile and infertile men, excluding a role of the FSH receptor genotype in male fertility determination. Likewise, mutations of the FSH receptor were not found to play a pathogenetic role in the spermatogenetic failure of the patients analyzed in this study, extending previous observations (7, 17) . Previous studies had shown that serum FSH is bioactive (32) and excluded the occurrence of circulating inhibitors of the FSH receptor in infertile men (33) . Thus, FSH action is not impaired in patients with idiopathic azoospermia or severe oligozoospermia, and the cause of their infertility remains to be determined. Compared to the other glycoprotein hormone receptors, mutations of the FSH receptor appear to be extremely rare (16, 34, 35) . This is compatible with an irreplaceable role of FSH in human reproduction so that mutations affecting its action are selfeliminating. Finally, the coexistence of both FSH and FSH receptor isoforms supports the idea of an ongoing process of coevolution of ligand-receptor pairs that might be necessary for improving the reproductive function of the species (36) .
